GlucoTrack, Inc. Files 8-K

Ticker: GCTK · Form: 8-K · Filed: May 16, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateMay 16, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: disclosure, financials

TL;DR

GlucoTrack filed an 8-K, likely with financial updates. Check for details.

AI Summary

GlucoTrack, Inc. filed an 8-K on May 16, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ. The filing does not contain specific financial figures or details about the nature of the disclosure.

Why It Matters

This 8-K filing indicates that GlucoTrack, Inc. is making a public disclosure and submitting financial exhibits, which could contain important updates for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for disclosure and exhibits, with no immediate indication of significant negative events.

Key Players & Entities

FAQ

What is the specific nature of the Regulation FD Disclosure?

The filing does not specify the details of the Regulation FD Disclosure, only that it is being reported.

Are there any new financial statements or exhibits included with this filing?

Yes, the filing indicates that Financial Statements and Exhibits are being submitted as part of this 8-K.

When was GlucoTrack, Inc. formerly known as Integrity Applications, Inc.?

The company's name was changed from Integrity Applications, Inc. on December 3, 2010.

What is the primary business of GlucoTrack, Inc.?

GlucoTrack, Inc. is in the Surgical & Medical Instruments & Apparatus industry (SIC code 3841).

Where are GlucoTrack, Inc.'s principal executive offices located?

The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-05-16 08:42:45

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 16, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing